Company
United StatesPublic company, NASDAQ: ACADAcadia Pharmaceuticals Inc. (NASDAQ: ACAD), Princeton, NJ – FDA Inspections
Inspection records and compliance data for Acadia Pharmaceuticals Inc. in Princeton, NJ. 1 FDA inspection on record, last inspected March 10, 2026. Publicly traded as NASDAQ: ACAD.
Company Profile
This profile covers Acadia Pharmaceuticals Inc. based in Princeton, NJ, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 10, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 10, 2026 | Not classified | Human Drugs | 1309598 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Acadia Pharmaceuticals Inc.
Stock ticker
ACAD
Exchange
NASDAQ
Share price
$18.14
Market cap
$3.1B
Price as of
November 13, 2026
FEI Number
3014529819
Address
502 Carnegie Ctr Ste 300, Princeton, NJ 08540-6289, United States
Country
United States
ID: 85d7df90-377b-4530-a97b-f8995bae30ec